Recognition of excellence in Victorian Advanced Manufacturing
10 May 2017, Melbourne: Australian pharmaceutical manufacturing and drug development company IDT Australia Limited (ASX: IDT) has received a Victorian Manufacturing Hall of Fame award in the High Growth Sector of Medical Technologies and Pharmaceuticals. The award recognises outstanding achievements by Victorian businesses which uphold a high standard of excellence in Victorian manufacturing. IDT’s Boronia based facility specialises in the manufacturing of difficult and dangerous to manufacture drugs, such as highly potent and cytotoxic medicines.
In receiving this award, IDT’s chair Graeme Kaufman said “We are honoured to receive this award from the Minister of Industry and Employment, The Hon. Wade Noonan MP. The Victorian Government has been and continues to be a strong supporter of IDT Australia’s efforts to develop and grow our advanced pharmaceutical manufacturing business.”
For further information please contact:
IDT Australia Limited
Dr Paul MacLeman
(03) 9801 8888
(03) 9620 3333
IDT Australia Ltd is developing a portfolio of 25 generic drugs to manufacture and sell via US distribution partners. With IDT’s 2016 temozolomide ANDA approval this signifies IDT’s move to rapidly become a specialty generics business with near term revenue upside.
IDT (ASX:IDT) is a public Australian pharmaceutical manufacturing company based in Boronia, Victoria, Australia. It has extensive experience in the development and production of high potency and high containment pharmaceutical products for local and international clients. IDT’s facilities are fully cGMP compliant and are regularly audited by the US FDA and Australian TGA. With an experienced team of specialists within world‐class facilities, IDT provides a fullscale service for new drug development and scale‐up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms.
Level 1, 121 William Street
Melbourne VIC 3000
Ph: 03 9620 3333